Hangzhou MacroLink Biopharmaceutical LLC
1 clinical trials · Sponsor
◉ Watch Hangzhou MacroLink Biopharmaceutical LLC
| Record | Firm | Date |
|---|---|---|
| A First-in-human (FIH), Open-Label, Dose Escalation and Expansion Cohorts Study of MC002 (NCT07726212) | Hangzhou MacroLink Biopharmaceutical LLC | 2026-09-01 |
Track Hangzhou MacroLink Biopharmaceutical LLC automatically
Every clearance here is in the API, with alerts when new ones post.